H.6 investigation summary: the complaint investigation for discrepant results when using the bd max¿ ct/gc/tv (ref.(b)(4), lots 2067778 and 2025616 was performed by the review of manufacturing records, review of customer¿s data and verification of complaints history.Review of the manufacturing records of the bd max¿ ct/gc/tv indicated that lots 2067778 and 2025616 were manufactured according to specifications and met performance requirements.The samples were repeated from a new collection sample taken after two, six or eleven days from the initial collect, depending on the sample, and gave a negative result in the repeat test (run 5615/a7, run 5526/a12 and run 5562/a3), without treatment having been given to the patients.Manual pcr curve adjudication of the six samples (three positive and three negative results) was done and revealed true but late amplification of the ct target for the three positive results, without anomaly.Late positive samples can occur due to targets load in the specimen being at or near the limit of detection of the assay or through environmental or cross contamination introduced during the sample preparation at the customer¿s site.Nevertheless, manual curve adjudication has limitations; visual examination of pcr curves for low signal is a conservative assessment of the data.Pcr curves analysis of the three repeat tests showed flat curves with no amplification in the ct target channel.No anomaly was observed in the repeat test.Overall, no product issue is suspected.There is no indication of a reagent issue based on the analysis of the complaints received for discrepant results on bd max¿ ct/gc/tv lots 2067778 and 2025616.The root cause was not identified.However, positives samples at the limit of detection of the assay or an environmental / cross contamination can explain the customer's positive results.Bd cannot confirm the complaint based on the investigation that was performed.H3 other text : see h.10.
|